Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in the United States of America (USA). This trial compares the changes in HbA1c after 26 weeks of repaglinide and metformin fixed dose combination tablet given as twice daily versus three times daily regimens or versus twice daily rosiglitazone and metformin fixed dose combination tablet in subjects with type 2 diabetes currently on monotherapy.

Key facts

Study ID

NCT00399711

Run by

Novo Nordisk A/S

People needed

560

Starts

2006-11-01

Expected to finish

2007-11-01

Last updated by the study team

2017-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes for at least 3 months
• HbA1c between 7.5-11.0% on monotherapy or
• HbA1c between 7.0-10.0% on dual therapy
• BMI maximum 45 kg/m2

You may not qualify if…

• Any clinically significant disease history in the opinion of the investigator
• Severe heart disease
• Pregnancy

Where it is running

• Novo Nordisk Investigational Site — Glendale, Arizona, United States
• Novo Nordisk Investigational Site — Mesa, Arizona, United States
• Novo Nordisk Investigational Site — Jonesboro, Arkansas, United States
• Novo Nordisk Investigational Site — Chula Vista, California, United States
• Novo Nordisk Investigational Site — Long Beach, California, United States
• Novo Nordisk Investigational Site — Los Angeles, California, United States
• Novo Nordisk Investigational Site — Poway, California, United States
• Novo Nordisk Investigational Site — Redlands, California, United States
• Novo Nordisk Investigational Site — Sacramento, California, United States
• Novo Nordisk Investigational Site — San Diego, California, United States
• Novo Nordisk Investigational Site — San Diego, California, United States
• Novo Nordisk Investigational Site — San Mateo, California, United States
• Novo Nordisk Investigational Site — Spring Valley, California, United States
• Novo Nordisk Investigational Site — Colorado Springs, Colorado, United States
• Novo Nordisk Investigational Site — Hamden, Connecticut, United States
• Novo Nordisk Investigational Site — Stamford, Connecticut, United States
• Novo Nordisk Investigational Site — Aventura, Florida, United States
• Novo Nordisk Investigational Site — Clearwater, Florida, United States
• Novo Nordisk Investigational Site — Daytona Beach, Florida, United States
• Novo Nordisk Investigational Site — Inverness, Florida, United States
• Novo Nordisk Investigational Site — Jacksonville, Florida, United States
• Novo Nordisk Investigational Site — Jacksonville, Florida, United States
• Novo Nordisk Investigational Site — Jacksonville, Florida, United States
• Novo Nordisk Investigational Site — Longwood, Florida, United States
• Novo Nordisk Investigational Site — Vestavia Hills, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.